Quantcast

Latest cervical cancer Stories

2014-08-27 08:27:38

KIGALI, Rwanda, Aug. 27, 2014 /PRNewswire-USNewswire/ -- Seraphine Mukandutiye, 50, is a Rwandan woman with a beautiful and glowing smile. But beneath her soft heart and warm smile, lies a deadly monster waiting to strike. She is battling a cervical cancer. The preventable cancer results from a genital infection caused by a Human Papilloma Virus (HPV). Hundreds of Rwandan women are suffering from the silent killer, others have died. The cancer is one of the major killers among...

2014-08-25 08:27:55

SEATTLE, Aug. 25, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that results from two independent clinical studies were presented at the 29th International Papillomavirus (IPV) Conference. Results from both pilot studies consistently demonstrated that the Company's urine-based assay for the detection of high-risk HPV had high sensitivity (greater than 90%) for identifying women with high grade cervical...

2014-08-22 12:25:19

LA JOLLA, Cali., Aug. 22, 2014 /PRNewswire/ -- Research presented at the 29(th) Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer. When tested in several cultured human cell models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to Louise T. Chow, Ph.D. and Thomas Broker, Ph.D., who...

2014-08-20 08:27:55

SAN DIEGO, Aug. 20, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus (IPV) conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus (HPV). The IPV conference is scheduled to take place in Seattle from August 21(st) to 25(th). Additionally, a new U.S. patent...

2014-08-11 08:29:29

HPV Immune Therapy VGX-3100 to Advance into Phase III PLYMOUTH MEETING, Penn., Aug. 11, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. Total operating expenses were $14.0 million and $26.3 million for the three and six months...

2014-08-07 12:27:30

CryoPen, Inc. Explains to African and U.S. First Ladies How the CryoPen® Cryosurgical System Treats Cervical Cancer DALLAS, Aug. 7, 2014 /PRNewswire/ -- As part of the Investing In Our Future at the U.S. - Africa Leaders Summit hosted by First Lady Mrs. Michelle Obama and former First Lady Mrs. Laura Bush, Cryopen, Inc. participated in a Summit Marketplace on August 6, and presented the CryoPen® Cryosurgical System for Cervical Cancer Treatment to U.S. and African First Ladies and...

2014-08-01 12:26:13

CHICAGO, Aug. 1. 2014 /PRNewswire-USNewswire/ -- As one of the 10 largest medical exhibitions in the U.S., the 2014 AACC Annual Meeting & Clinical Lab Expo is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world. This year, many of the trailblazing products displayed by the Expo's 650 exhibitors will include the latest diagnostic technology in the field of mobile health....

2014-08-01 10:49:36

Landes Bioscience A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than nine years, and vaccine efficacy (VE) against incident infection was 100%. This is the longest follow-up report for a licensed HPV vaccine. Visit https://www.landesbioscience.com/journals/vaccines/article/29532/...

2014-07-28 23:01:59

Individuals diagnosed with a covered Cancer on or prior to October 12, 2012 are included in the October 12, 2014 deadline. Port Washington, NY (PRWEB) July 28, 2014 Parker Waichman LLP, a personal injury law firm that has spent many years fighting to ensure that the heroes of 9/11 are never forgotten, comments that the September 11th Victims Compensation Fund (VCF) has announced an important deadline. According to a VCF message dated July 3, 2014, individuals who were diagnosed with a...

2014-07-28 10:35:17

Brigham and Women's Hospital Researchers demonstrate novel approach in cervical cancer prevention A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix. The findings come from a study that looked at squamocolumnar junction cells, or SCJ cells. These cells...


Latest cervical cancer Reference Libraries

Colposcopy
2013-01-18 11:34:29

The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...

Colposcopy
2012-12-31 11:42:30

The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (3 articles) »
Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related